Exactech, Inc. (NASDAQ:EXAC) shares rose 19.1% on Tuesday . The stock traded as high as $50.95 and last traded at $50.42. Approximately 513,500 shares changed hands during trading, an increase of 638% from the average daily volume of 69,586 shares. The stock had previously closed at $42.35.

EXAC has been the topic of several research reports. Robert W. Baird downgraded shares of Exactech from an “outperform” rating to a “neutral” rating and set a $42.00 price objective on the stock. in a report on Monday, October 23rd. ValuEngine downgraded shares of Exactech from a “buy” rating to a “hold” rating in a report on Friday. Sidoti downgraded shares of Exactech from a “buy” rating to a “neutral” rating in a report on Monday, October 23rd. BidaskClub upgraded shares of Exactech from a “sell” rating to a “hold” rating in a report on Friday, August 18th. Finally, Gabelli downgraded shares of Exactech from a “buy” rating to a “hold” rating in a report on Tuesday, October 24th. One investment analyst has rated the stock with a sell rating and five have assigned a hold rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $42.00.

The company has a debt-to-equity ratio of 0.06, a current ratio of 4.08 and a quick ratio of 2.09. The firm has a market cap of $608.41, a price-to-earnings ratio of 35.00, a price-to-earnings-growth ratio of 3.63 and a beta of 1.02.

Exactech (NASDAQ:EXAC) last released its quarterly earnings data on Monday, October 30th. The medical equipment provider reported $0.20 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.23 by ($0.03). Exactech had a return on equity of 7.22% and a net margin of 0.18%. The business had revenue of $61.40 million for the quarter, compared to analyst estimates of $61.78 million. analysts forecast that Exactech, Inc. will post 1.29 earnings per share for the current year.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Algert Global LLC grew its stake in shares of Exactech by 58.0% in the 3rd quarter. Algert Global LLC now owns 77,068 shares of the medical equipment provider’s stock worth $2,539,000 after acquiring an additional 28,292 shares in the last quarter. Highbridge Capital Management LLC bought a new stake in shares of Exactech in the 3rd quarter worth $201,000. AMP Capital Investors Ltd bought a new stake in shares of Exactech in the 3rd quarter worth $215,000. Dimensional Fund Advisors LP grew its stake in shares of Exactech by 5.6% in the 3rd quarter. Dimensional Fund Advisors LP now owns 874,161 shares of the medical equipment provider’s stock worth $28,803,000 after acquiring an additional 46,400 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. grew its stake in shares of Exactech by 11.6% in the 3rd quarter. Schwab Charles Investment Management Inc. now owns 78,386 shares of the medical equipment provider’s stock worth $2,583,000 after acquiring an additional 8,138 shares in the last quarter. Hedge funds and other institutional investors own 66.44% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Exactech (EXAC) Stock Price Up 19.1%” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international copyright laws. The legal version of this story can be accessed at https://www.thecerbatgem.com/2017/12/05/exactech-exac-stock-price-up-19-1.html.

Exactech Company Profile

Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines.

Receive News & Stock Ratings for Exactech Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech Inc. and related stocks with our FREE daily email newsletter.